Speaker Biography
Stephen Perry
Stephen M. Perry, PMP is the founder and president of Kymanox – a company specializing in project management and technology transfer for companies in the pharmaceutical, biotechnology and life science industries. He has a over decade of cGMP biopharma manufacturing experience as a process engineer and technical project manager, has led three multi-million dollar capital projects and has contributed to five major facility installations which began at the conceptual design phase. Before starting Kymanox, Perry had various leadership roles supporting scale-up, start-up and commercialization initiatives at Abbott Laboratories, Covance Biotechnology Services, Diosynth Biotechnology and Human Genome Sciences. During his career, he has participated with increasing responsibilities in the FDA commercial approval of unique Phase III products such Cyclosporine (Gengraf®), Aminoethoxy-Vinyl-Glycine (ReTain®) and Pegvisomant (SOMAVERT®). Additionally, he was the operations technical lead for the commercial transfer of Reteplase (Retavase®) from Germany to a US CMO. His Phase III technology transfer work with HspE7, a novel cancer drug, and Everninomycin, a super-potent antibiotic, are notable from a technology transfer perspective. Perry has a liberal education background with a high-honors Bachelor’s degree in chemical engineering from the University of Notre Dame and studied at the graduate level at Purdue University. He is Member of the International Society of Pharmaceutical Engineering (ISPE) and is a certified Project Management Professional (PMP) by the Project Management Institute (PMI).